<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jba.sagepub.com">
<title>Journal of Biomaterials Applications current issue</title>
<link>http://jba.sagepub.com</link>
<description>Journal of Biomaterials Applications RSS feed -- current issue</description>
<prism:coverDisplayDate>November 2009</prism:coverDisplayDate>
<prism:publicationName>Journal of Biomaterials Applications</prism:publicationName>
<prism:issn>0885-3282</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jba.sagepub.com/cgi/content/abstract/24/4/293?rss=1" />
  <rdf:li rdf:resource="http://jba.sagepub.com/cgi/content/abstract/24/4/309?rss=1" />
  <rdf:li rdf:resource="http://jba.sagepub.com/cgi/content/abstract/24/4/327?rss=1" />
  <rdf:li rdf:resource="http://jba.sagepub.com/cgi/content/abstract/24/4/343?rss=1" />
  <rdf:li rdf:resource="http://jba.sagepub.com/cgi/content/abstract/24/4/353?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://jba.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://jba.sagepub.com:80/icons/banner/title.gif">
<title>Journal of Biomaterials Applications</title>
<url>http://jba.sagepub.com:80/icons/banner/title.gif</url>
<link>http://jba.sagepub.com</link>
</image>

<item rdf:about="http://jba.sagepub.com/cgi/content/abstract/24/4/293?rss=1">
<title><![CDATA[Review Paper: Role of Aluminum in Glass-ionomer Dental Cements and its Biological Effects]]></title>
<link>http://jba.sagepub.com/cgi/content/abstract/24/4/293?rss=1</link>
<description><![CDATA[<p>The role of aluminum in glass-ionomers and resin-modified glass-ionomers for dentistry is reviewed. Aluminum is included in the glass component of these materials in the form of Al<SUB>2</SUB>O<SUB>3</SUB> to confer basicity on the glass and enable the glass to take part in the acid&mdash;base setting reactions. Results of studies of these reactions by FTIR and magic-angle spinning (MAS)-NMR spectroscopy are reported and the role of aluminum is discussed in detail. Aluminum has been shown to be present in the glasses in predominantly 4-coordination, as well as 5- and 6-coordination, and during setting a proportion of this is converted to 6-coordinate species within the matrix of the cement. Despite this, mature cements may contain detectable amounts of both 4- and 5-coordinate aluminum. Aluminum has been found to be leached from glass-ionomer cements, with greater amounts being released under acidic conditions. It may be associated with fluoride, with which it is known to complex strongly. Aluminum that enters the body via the gastro-intestinal tract is mainly excreted, and only about 1% ingested aluminum crosses the gut wall. Calculation shows that, if a glass-ionomer filling dissolved completely over 5 years, it would add only an extra 0.5% of the recommended maximum intake of aluminum to an adult patient. This leads to the conclusion that the release of aluminum from either type of glass-ionomer cement in the mouth poses a negligible health hazard.</p>]]></description>
<dc:creator><![CDATA[Nicholson, J. W., Czarnecka, B.]]></dc:creator>
<dc:date>Fri, 23 Oct 2009 04:11:34 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0885328209344441</dc:identifier>
<dc:title><![CDATA[Review Paper: Role of Aluminum in Glass-ionomer Dental Cements and its Biological Effects]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>308</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>293</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jba.sagepub.com/cgi/content/abstract/24/4/309?rss=1">
<title><![CDATA[Evaluation of Parenteral Depot Insulin Formulation using PLGA and PLA Microparticles]]></title>
<link>http://jba.sagepub.com/cgi/content/abstract/24/4/309?rss=1</link>
<description><![CDATA[<p>PLGA and PLA microparticles entrapping insulin are prepared by solvent evaporation method and are evaluated in diabetes-induced rat for its efficacy in maintaining blood sugar level from a single intramuscular dose. In vitro release of insulin from PLGA and PLA microparticles are 75.35 &plusmn; 1.73% and 67.536 &plusmn; 2.23%, respectively in 168 h (7 days). Released insulin from polymer particles are mostly in monomeric form without aggregation. Optimal use of stabilizers during particle formulation helps in reducing protein denaturation and thus results in stabilized insulin-loaded polymer particles. Intramuscular administration of insulin-loaded PLGA (50 : 50) and PLA microparticles (equivalent to 25 IU insulin/kg of animal weight) in alloxaninduced diabetic rats result in 53.86 &plusmn; 4.2% and 39.52 &plusmn; 6.7% reduction in blood glucose level, respectively in 96 h. This effect continued up to 7 days in case of PLGA and PLA microparticles.</p>]]></description>
<dc:creator><![CDATA[Naha, P. C., Kanchan, V., Panda, A. K.]]></dc:creator>
<dc:date>Fri, 23 Oct 2009 04:11:35 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0885328208096238</dc:identifier>
<dc:title><![CDATA[Evaluation of Parenteral Depot Insulin Formulation using PLGA and PLA Microparticles]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>325</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>309</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jba.sagepub.com/cgi/content/abstract/24/4/327?rss=1">
<title><![CDATA[Enhanced Regeneration of Critical Bone Defects Using a Biodegradable Gelatin Sponge and {beta}-Tricalcium Phosphate with Bone Morphogenetic Protein-2]]></title>
<link>http://jba.sagepub.com/cgi/content/abstract/24/4/327?rss=1</link>
<description><![CDATA[<p>We examine the osteogenicity of a sponge biomaterial consisting of a biodegradable mixture of gelatin and &beta;-tricalcium phosphate (&beta;TCP) that bound bone morphogenetic protein 2 (BMP-2) in critical-sized bone defects in rats. Gelatin-&beta;TCP sponges containing either phosphate buffered saline or incorporating BMP-2 are implanted into 5 mm diameter bone defects created in rat mandibles. We assess the defects biweekly for 8 weeks following implantation. There is significantly higher osteoinductive activity and significantly more Gla-osteocalcin content at bone-defect healing sites treated with gelatin-&beta;TCP sponges incorporating BMP-2 than there is in those treated with sponges that did not contain BMP-2. Histologically, new bone that contains bone marrow and that is connected to the original bone almost entirely replaces the regenerated bone. These results show that biodegradable gelatin-&beta;TCP incorporating BMP-2 is osteogenic enough to promote healing in large bone defects.</p>]]></description>
<dc:creator><![CDATA[Matsumoto, G., Omi, Y., Kubota, E., Ozono, S., Tsuzuki, H., Kinoshita, Y., Yamamoto, M., Tabata, Y.]]></dc:creator>
<dc:date>Fri, 23 Oct 2009 04:11:35 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0885328208096523</dc:identifier>
<dc:title><![CDATA[Enhanced Regeneration of Critical Bone Defects Using a Biodegradable Gelatin Sponge and {beta}-Tricalcium Phosphate with Bone Morphogenetic Protein-2]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>342</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>327</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jba.sagepub.com/cgi/content/abstract/24/4/343?rss=1">
<title><![CDATA[Effect of Cryoprotectant Incubation Time on Handling Properties of Allogeneic Tendons Prepared for Knee Ligament Reconstruction]]></title>
<link>http://jba.sagepub.com/cgi/content/abstract/24/4/343?rss=1</link>
<description><![CDATA[<p>Soft tissue tendon allografts prepared for anterior cruciate ligament reconstruction are becoming increasingly popular; although concerns exist regarding increased long-term laxity and traumatic rupture rates. This qualitative study evaluated the tissue handling properties of human tibialis posterior tendons prepared using a patented process to improve allograft remodeling and ligamentization under differing cryoprotectant incubation times over 60-min rehydration. Tendons that had been incubated for 8 h had smaller diameters than those that were incubated for 2 h (8.5 &plusmn; 1.5 mm vs. 9.1 &plusmn; 1.3 mm, p = 0.02). Qualitative tissue handling property results indicated that the 8-h incubation had a negative affect on tissue color. Both incubation time and rehydration time influenced tensile stiffness, compressive resilience, and ease of tissue handling for allograft preparation with the 8-h group displaying poorer results. This study concludes that an 8-h cryoprotectant incubation time is detrimental to qualitative allogeniec tibialis posterior tendon properties. Both groups tended to improve with longer rehydration times, however the 8-h incubation group remained actively dehydrated as evidenced by its smaller diameter and poorer tissue handling properties. Suboptimally rehydrated tendons would be more likely to accrue damage during allograft preparation or during implantation.</p>]]></description>
<dc:creator><![CDATA[Henson, J., Nyland, J., Chang, H. C., Caborn, D. N.M.]]></dc:creator>
<dc:date>Fri, 23 Oct 2009 04:11:35 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0885328208096524</dc:identifier>
<dc:title><![CDATA[Effect of Cryoprotectant Incubation Time on Handling Properties of Allogeneic Tendons Prepared for Knee Ligament Reconstruction]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>352</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>343</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://jba.sagepub.com/cgi/content/abstract/24/4/353?rss=1">
<title><![CDATA[Acrylic Copolymers as Candidates for Drug-Eluting Coating of Vascular Stents]]></title>
<link>http://jba.sagepub.com/cgi/content/abstract/24/4/353?rss=1</link>
<description><![CDATA[<p>The aim of the present work is the synthesis and characterization of polymer materials showing good adhesion, drug loading, and delivery properties, for potential cardiovascular application. In particular, poly(methylmethacrylate-co-acrylic acid) copolymers are prepared in different compositions by a radical polymerization and investigated as potential materials to coat metallic stents and to carry out a local drug release. Films obtained by dissolving the copolymer in an appropriate organic solvent (also loaded with an anti-restenosis drug, such as tacrolimus) are investigated: physicochemical properties, adhesiveness to metallic stent material, and kinetics of drug release in physiological environment are studied.</p>]]></description>
<dc:creator><![CDATA[Silvestri, D., Cristallini, C., Gagliardi, M., Barbani, N., D'Acunto, M., Ciardelli, G., Giusti, P.]]></dc:creator>
<dc:date>Fri, 23 Oct 2009 04:11:35 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0885328208095198</dc:identifier>
<dc:title><![CDATA[Acrylic Copolymers as Candidates for Drug-Eluting Coating of Vascular Stents]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>383</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>353</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

</rdf:RDF>